$3.57 Billion is the total value of Redmile Group, LLC's 69 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 35.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $249,125,000 | +13.5% | 11,216,809 | 0.0% | 6.98% | +33.0% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $232,677,000 | -5.2% | 25,181,500 | -0.1% | 6.52% | +11.1% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $210,637,000 | -28.1% | 5,116,263 | +8.6% | 5.90% | -15.8% |
| BIIB | Buy | BIOGEN INC | $186,443,000 | +37.3% | 589,300 | +28.8% | 5.23% | +61.0% |
| IGMS | IGM BIOSCIENCES INC | $176,536,000 | +47.1% | 3,144,000 | 0.0% | 4.95% | +72.4% | |
| ARGX | Sell | ARGENX SEsponsored adr | $142,541,000 | -23.0% | 1,082,070 | -6.2% | 4.00% | -9.8% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $140,760,000 | +120.4% | 5,175,008 | +59.8% | 3.95% | +158.2% |
| EPZM | Buy | EPIZYME INC | $135,999,000 | -36.8% | 8,768,475 | +0.3% | 3.81% | -25.9% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $134,263,000 | -10.0% | 2,261,088 | -16.9% | 3.76% | +5.5% |
| ALLK | Sell | ALLAKOS INC | $132,444,000 | -54.2% | 2,976,928 | -1.9% | 3.71% | -46.3% |
| QURE | Buy | UNIQURE NV | $131,604,000 | -28.1% | 2,773,525 | +8.6% | 3.69% | -15.7% |
| APRE | APREA THERAPEUTICS INC | $78,861,000 | -24.3% | 2,268,718 | 0.0% | 2.21% | -11.2% | |
| RGNX | Sell | REGENXBIO INC | $75,720,000 | -26.3% | 2,338,466 | -6.8% | 2.12% | -13.6% |
| SGEN | New | SEATTLE GENETICS INC | $75,655,000 | – | 655,700 | +100.0% | 2.12% | – |
| NVRO | Sell | NEVRO CORP | $70,628,000 | -36.0% | 706,426 | -24.8% | 1.98% | -25.0% |
| MRK | New | MERCK & CO. INC | $60,667,000 | – | 788,500 | +100.0% | 1.70% | – |
| BEAM | New | BEAM THERAPEUTICS INC | $60,467,000 | – | 3,359,258 | +100.0% | 1.70% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $60,126,000 | +0.7% | 241,100 | +18.7% | 1.69% | +18.1% |
| IMGN | Buy | IMMUNOGEN INC | $57,063,000 | -23.6% | 16,733,879 | +14.3% | 1.60% | -10.5% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $56,709,000 | -18.8% | 881,266 | -24.8% | 1.59% | -4.8% |
| ONEM | New | 1LIFE HEALTHCARE INC | $56,689,000 | – | 3,123,384 | +100.0% | 1.59% | – |
| NVS | Buy | NOVARTIS A Gsponsored adr | $53,889,000 | -0.7% | 653,600 | +14.0% | 1.51% | +16.4% |
| CI | Buy | CIGNA CORP NEW | $53,260,000 | +76.6% | 300,600 | +103.8% | 1.49% | +107.1% |
| STOK | Buy | STOKE THERAPEUTICS INC | $49,600,000 | +71.6% | 2,165,938 | +112.2% | 1.39% | +101.3% |
| CNC | Sell | CENTENE CORP DEL | $48,959,000 | -49.8% | 824,090 | -46.9% | 1.37% | -41.2% |
| TCDA | Sell | TRICIDA INC | $46,785,000 | -41.8% | 2,126,600 | -0.1% | 1.31% | -31.7% |
| NLTX | Buy | NEOLEUKIN THERAPEUTICS INC | $45,989,000 | +94.3% | 4,041,211 | +110.4% | 1.29% | +127.7% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $45,480,000 | -24.7% | 1,051,800 | -3.5% | 1.28% | -11.7% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $45,047,000 | -41.2% | 5,293,370 | +13.9% | 1.26% | -31.0% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $38,303,000 | -9.8% | 1,507,400 | -1.6% | 1.07% | +5.8% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $36,762,000 | -26.5% | 442,700 | -1.6% | 1.03% | -13.8% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $34,999,000 | -9.7% | 2,890,089 | -1.7% | 0.98% | +5.8% |
| DXCM | New | DEXCOM INC | $34,817,000 | – | 129,300 | +100.0% | 0.98% | – |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $33,778,000 | -16.1% | 689,478 | -1.7% | 0.95% | -1.7% |
| GMAB | Buy | GENMAB A/Ssponsored ads | $32,823,000 | +56.9% | 1,549,000 | +65.4% | 0.92% | +84.0% |
| AMED | Sell | AMEDISYS INC | $32,590,000 | +7.8% | 177,565 | -1.9% | 0.91% | +26.4% |
| CYRX | Buy | CRYOPORT INC | $31,028,000 | +123.8% | 1,817,663 | +115.8% | 0.87% | +162.0% |
| ZYME | New | ZYMEWORKS INC | $30,809,000 | – | 868,600 | +100.0% | 0.86% | – |
| REPL | Buy | REPLIMUNE GROUP INC | $29,716,000 | -25.1% | 2,980,493 | +7.7% | 0.83% | -12.3% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $27,429,000 | +2.9% | 2,927,352 | -12.0% | 0.77% | +20.5% |
| CTLT | New | CATALENT INC | $26,302,000 | – | 506,300 | +100.0% | 0.74% | – |
| PPD | New | PPD INC | $22,990,000 | – | 1,290,832 | +100.0% | 0.64% | – |
| ARDX | Sell | ARDELYX INC | $22,195,000 | -26.1% | 3,904,100 | -2.4% | 0.62% | -13.4% |
| ODT | Sell | ODONATE THERAPEUTICS INC | $19,549,000 | -23.7% | 708,038 | -10.4% | 0.55% | -10.6% |
| BCEL | Sell | ATRECA INC | $18,682,000 | +6.2% | 1,128,806 | -0.7% | 0.52% | +24.5% |
| SWAV | Sell | SHOCKWAVE MED INC | $18,508,000 | -25.8% | 557,800 | -1.8% | 0.52% | -13.1% |
| TWST | New | TWIST BIOSCIENCE CORP | $18,048,000 | – | 590,200 | +100.0% | 0.51% | – |
| GRTS | Sell | GRITSTONE ONCOLOGY INC | $17,857,000 | -36.1% | 3,068,194 | -1.6% | 0.50% | -25.1% |
| HOOK | Sell | HOOKIPA PHARMA INC | $15,366,000 | -33.6% | 1,862,510 | -1.6% | 0.43% | -22.2% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $13,679,000 | -46.8% | 1,767,288 | -1.8% | 0.38% | -37.7% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $12,074,000 | -53.3% | 569,513 | -51.1% | 0.34% | -45.3% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $11,512,000 | -9.6% | 414,400 | -2.7% | 0.32% | +5.9% |
| CABA | Sell | CABALETTA BIO INC | $10,409,000 | -48.0% | 1,425,896 | -0.4% | 0.29% | -38.9% |
| BNTX | Sell | BIONTECH SEsponsored ads | $9,940,000 | +69.1% | 170,200 | -1.9% | 0.28% | +97.9% |
| STXS | Sell | STEREOTAXIS INC | $9,372,000 | -44.1% | 3,103,327 | -2.1% | 0.26% | -34.4% |
| BMYRT | New | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $9,078,000 | – | 2,389,000 | +100.0% | 0.26% | – |
| ITMR | New | ITAMAR MED LTDsponsored ads | $7,363,000 | – | 625,000 | +100.0% | 0.21% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $6,647,000 | – | 303,371 | +100.0% | 0.19% | – |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $5,767,000 | -72.7% | 2,957,441 | -1.4% | 0.16% | -68.0% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $4,071,000 | -26.2% | 2,750,616 | -2.2% | 0.11% | -13.6% |
| PROF | New | PROFOUND MED CORP | $3,896,000 | – | 400,000 | +100.0% | 0.11% | – |
| GOSS | Sell | GOSSAMER BIO INC | $2,636,000 | -35.2% | 259,700 | -0.2% | 0.07% | -23.7% |
| SYRS | SYROS PHARMACEUTICALS INC | $1,259,000 | -14.2% | 212,291 | 0.0% | 0.04% | 0.0% | |
| CLVS | New | CLOVIS ONCOLOGY INC | $633,000 | – | 99,485 | +100.0% | 0.02% | – |
| GLYC | Sell | GLYCOMIMETICS INC | $578,000 | -91.9% | 253,516 | -81.1% | 0.02% | -90.6% |
| VAPO | Sell | VAPOTHERM INC | $471,000 | -96.0% | 25,000 | -97.4% | 0.01% | -95.3% |
| OVID | OVID THERAPEUTICS INC | $363,000 | -28.3% | 121,950 | 0.0% | 0.01% | -16.7% | |
| ELGXQ | ENDOLOGIX INC | $54,000 | -56.5% | 78,755 | 0.0% | 0.00% | -33.3% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $7,000 | -50.0% | 10,229 | 0.0% | 0.00% | – | |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -613,734 | -100.0% | -0.39% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -100,800 | -100.0% | -0.73% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -389,700 | -100.0% | -0.73% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -639,095 | -100.0% | -0.92% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -859,526 | -100.0% | -0.99% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -285,200 | -100.0% | -1.01% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -1,631,200 | -100.0% | -1.76% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -2,770,842 | -100.0% | -2.61% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -1,800,800 | -100.0% | -2.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.